EU Approves Extended Libtayo Dosing and Faster Infusions
The approval introduces a 700 mg Libtayo regimen every six weeks. The supplied text does not specify the remainder of the dosing details.
Story updates
12:03:31 PM UTC
SquawkNews
REGENERON PHARMACEUTICALS - APPROVAL INTRODUCES LIBTAYO 700 MG EVERY SIX WEEKS AFTER INITIAL 12 WEEK